APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Verapamil

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Verapamil Industry Growth and Trends Forecast to 2032

Report ID 17404578012 January 202698 pages

Choose your research edition.

Industry ResearchVerapamil Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Verapamil Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Verapamil Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Verapamil Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Verapamil Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Verapamil market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Verapamil is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Verapamil is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Verapamil is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Verapamil include REPLEK FARM, YUNGSHIN PHARM IND. CO. LTD, The Central Pharmaceutical CO.,Ltd.Tianjin, Mylan and Abbott Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Verapamil market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Verapamil market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Verapamil market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Verapamil.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Verapamil market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Verapamil Market by Company

REPLEK FARM

YUNGSHIN PHARM IND. CO. LTD

The Central Pharmaceutical CO.,Ltd.Tianjin

Mylan

Abbott Laboratories

Verapamil Segment by Type

Capsules

Tablets

Injection

Others

Verapamil Segment by Application

Hospital Pharmacy

Online Sales

Retail Pharmacy

Others

Verapamil Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Verapamil market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Verapamil and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Verapamil.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Verapamil manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Verapamil in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Capsules Table 2. Major Company of Tablets Table 3. Major Company of Injection Table 4. Major Company of Others Table 5. Global Verapamil Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Verapamil Sales by Type (2021-2026) & (K Units) Table 7. Global Verapamil Sales Market Share in Volume by Type (2021-2026) Table 8. Global Verapamil Sales by Type (2021-2026) & (US$ Million) Table 9. Global Verapamil Sales Market Share in Value by Type (2021-2026) Table 10. Global Verapamil Price by Type (2021-2026) & (US$/Unit) Table 11. Global Verapamil Sales by Type (2027-2032) & (K Units) Table 12. Global Verapamil Sales Market Share in Volume by Type (2027-2032) Table 13. Global Verapamil Sales by Type (2027-2032) & (US$ Million) Table 14. Global Verapamil Sales Market Share in Value by Type (2027-2032) Table 15. Global Verapamil Price by Type (2027-2032) & (US$/Unit) Table 16. North America Verapamil Sales by Type (2021-2026) & (K Units) Table 17. North America Verapamil Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Verapamil Sales by Type (2021-2026) & (K Units) Table 19. Europe Verapamil Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Verapamil Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Verapamil Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Verapamil Sales by Type (2021-2026) & (K Units) Table 23. Latin America Verapamil Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Verapamil Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Verapamil Sales by Type (2021-2026) & (US$ Million) Table 26. Verapamil Industry Trends Table 27. Verapamil Industry Drivers Table 28. Verapamil Industry Opportunities and Challenges Table 29. Verapamil Industry Restraints Table 30. Global Verapamil Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Verapamil Revenue Market Share by Company (2021-2026) Table 32. Global Verapamil Sales by Company (2021-2026) & (K Units) Table 33. Global Verapamil Sales Share by Company (2021-2026) Table 34. Global Verapamil Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Verapamil Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Verapamil Major Company Production Sites and Headquarters Table 37. Global Verapamil Company, Product Type & Application Table 38. Global Verapamil Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Verapamil by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Verapamil Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Verapamil Sales by Region (2021-2026) & (K Units) Table 43. Global Verapamil Sales Market Share in Volume by Region (2021-2026) Table 44. Global Verapamil Sales by Region (2021-2026) & (US$ Million) Table 45. Global Verapamil Sales Market Share in Value by Region (2021-2026) Table 46. Global Verapamil Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Verapamil Sales by Region (2027-2032) & (K Units) Table 48. Global Verapamil Sales Market Share in Volume by Region (2027-2032) Table 49. Global Verapamil Sales by Region (2027-2032) & (US$ Million) Table 50. Global Verapamil Sales Market Share in Value by Region (2027-2032) Table 51. Global Verapamil Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Verapamil Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Verapamil Sales by Application (2021-2026) & (K Units) Table 54. Global Verapamil Sales Market Share in Volume by Application (2021-2026) Table 55. Global Verapamil Sales by Application (2021-2026) & (US$ Million) Table 56. Global Verapamil Sales Market Share in Value by Application (2021-2026) Table 57. Global Verapamil Price by Application (2021-2026) & (US$/Unit) Table 58. Global Verapamil Sales by Application (2027-2032) & (K Units) Table 59. Global Verapamil Sales Market Share in Volume by Application (2027-2032) Table 60. Global Verapamil Sales by Application (2027-2032) & (US$ Million) Table 61. Global Verapamil Sales Market Share in Value by Application (2027-2032) Table 62. Global Verapamil Price by Application (2027-2032) & (US$/Unit) Table 63. North America Verapamil Sales by Application (2021-2026) & (K Units) Table 64. North America Verapamil Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Verapamil Sales by Application (2021-2026) & (K Units) Table 66. Europe Verapamil Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Verapamil Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Verapamil Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Verapamil Sales by Application (2021-2026) & (K Units) Table 70. Latin America Verapamil Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Verapamil Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Verapamil Sales by Application (2021-2026) & (US$ Million) Table 73. REPLEK FARM Company Information Table 74. REPLEK FARM Business Overview Table 75. REPLEK FARM Verapamil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. REPLEK FARM Verapamil Product Portfolio Table 77. REPLEK FARM Recent Development Table 78. YUNGSHIN PHARM IND. CO. LTD Company Information Table 79. YUNGSHIN PHARM IND. CO. LTD Business Overview Table 80. YUNGSHIN PHARM IND. CO. LTD Verapamil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. YUNGSHIN PHARM IND. CO. LTD Verapamil Product Portfolio Table 82. YUNGSHIN PHARM IND. CO. LTD Recent Development Table 83. The Central Pharmaceutical CO.,Ltd.Tianjin Company Information Table 84. The Central Pharmaceutical CO.,Ltd.Tianjin Business Overview Table 85. The Central Pharmaceutical CO.,Ltd.Tianjin Verapamil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. The Central Pharmaceutical CO.,Ltd.Tianjin Verapamil Product Portfolio Table 87. The Central Pharmaceutical CO.,Ltd.Tianjin Recent Development Table 88. Mylan Company Information Table 89. Mylan Business Overview Table 90. Mylan Verapamil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Mylan Verapamil Product Portfolio Table 92. Mylan Recent Development Table 93. Abbott Laboratories Company Information Table 94. Abbott Laboratories Business Overview Table 95. Abbott Laboratories Verapamil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Abbott Laboratories Verapamil Product Portfolio Table 97. Abbott Laboratories Recent Development Table 98. North America Verapamil Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 99. North America Verapamil Sales by Country (2021-2026) & (K Units) Table 100. North America Verapamil Sales Market Share by Country (2021-2026) Table 101. North America Verapamil Sales Forecast by Country (2027-2032) & (K Units) Table 102. North America Verapamil Sales Market Share Forecast by Country (2027-2032) Table 103. North America Verapamil Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. North America Verapamil Market Size by Country (2021-2026) & (US$ Million) Table 105. North America Verapamil Market Share by Country (2021-2026) Table 106. North America Verapamil Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. North America Verapamil Market Share Forecast by Country (2027-2032) Table 108. Europe Verapamil Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 109. Europe Verapamil Sales by Country (2021-2026) & (K Units) Table 110. Europe Verapamil Sales Market Share by Country (2021-2026) Table 111. Europe Verapamil Sales Forecast by Country (2027-2032) & (K Units) Table 112. Europe Verapamil Sales Market Share Forecast by Country (2027-2032) Table 113. Europe Verapamil Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Europe Verapamil Market Size by Country (2021-2026) & (US$ Million) Table 115. Europe Verapamil Market Share by Country (2021-2026) Table 116. Europe Verapamil Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Europe Verapamil Market Share Forecast by Country (2027-2032) Table 118. Asia-Pacific Verapamil Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 119. Asia-Pacific Verapamil Sales by Country (2021-2026) & (K Units) Table 120. Asia-Pacific Verapamil Sales Market Share by Country (2021-2026) Table 121. Asia-Pacific Verapamil Sales Forecast by Country (2027-2032) & (K Units) Table 122. Asia-Pacific Verapamil Sales Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Verapamil Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Verapamil Market Size by Country (2021-2026) & (US$ Million) Table 125. Asia-Pacific Verapamil Market Share by Country (2021-2026) Table 126. Asia-Pacific Verapamil Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Asia-Pacific Verapamil Market Share Forecast by Country (2027-2032) Table 128. Latin America Verapamil Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 129. Latin America Verapamil Sales by Country (2021-2026) & (K Units) Table 130. Latin America Verapamil Sales Market Share by Country (2021-2026) Table 131. Latin America Verapamil Sales Forecast by Country (2027-2032) & (K Units) Table 132. Latin America Verapamil Sales Market Share Forecast by Country (2027-2032) Table 133. Latin America Verapamil Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Latin America Verapamil Market Size by Country (2021-2026) & (US$ Million) Table 135. Latin America Verapamil Market Share by Country (2021-2026) Table 136. Latin America Verapamil Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Latin America Verapamil Market Share Forecast by Country (2027-2032) Table 138. Middle East and Africa Verapamil Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 139. Middle East and Africa Verapamil Sales by Country (2021-2026) & (K Units) Table 140. Middle East and Africa Verapamil Sales Market Share by Country (2021-2026) Table 141. Middle East and Africa Verapamil Sales Forecast by Country (2027-2032) & (K Units) Table 142. Middle East and Africa Verapamil Sales Market Share Forecast by Country (2027-2032) Table 143. Middle East and Africa Verapamil Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East and Africa Verapamil Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East and Africa Verapamil Market Share by Country (2021-2026) Table 146. Middle East and Africa Verapamil Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East and Africa Verapamil Market Share Forecast by Country (2027-2032) Table 148. Key Raw Materials Table 149. Raw Materials Key Suppliers Table 150. Verapamil Distributors List Table 151. Verapamil Customers List Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Verapamil Image Figure 2. Global Verapamil Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Verapamil Market Size (2021-2032) & (US$ Million) Figure 4. Global Verapamil Sales (2021-2032) & (K Units) Figure 5. Capsules Image Figure 6. Global Capsules Sales YoY Growth (2021-2032) & (K Units) Figure 7. Tablets Image Figure 8. Global Tablets Sales YoY Growth (2021-2032) & (K Units) Figure 9. Injection Image Figure 10. Global Injection Sales YoY Growth (2021-2032) & (K Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Verapamil Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Verapamil Market Share by Type 2025 VS 2032 Figure 15. North America Verapamil Sales Market Share in Volume by Type in 2025 Figure 16. North America Verapamil Sales Market Share in Value by Type in 2025 Figure 17. Europe Verapamil Sales Market Share in Volume by Type in 2025 Figure 18. Europe Verapamil Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Verapamil Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Verapamil Sales Market Share in Value by Type in 2025 Figure 21. Latin America Verapamil Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Verapamil Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Verapamil Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Verapamil Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Verapamil Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hospital Pharmacy Image Figure 28. Global Hospital Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 29. Online Sales Image Figure 30. Global Online Sales Sales YoY Growth (2021-2032) & (K Units) Figure 31. Retail Pharmacy Image Figure 32. Global Retail Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Verapamil Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Verapamil Market Share by Application 2025 VS 2032 Figure 37. North America Verapamil Sales Market Share in Volume by Application in 2025 Figure 38. North America Verapamil Sales Market Share in Value by Application in 2025 Figure 39. Europe Verapamil Sales Market Share in Volume by Application in 2025 Figure 40. Europe Verapamil Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Verapamil Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Verapamil Sales Market Share in Value by Application in 2025 Figure 43. Latin America Verapamil Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Verapamil Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Verapamil Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Verapamil Sales Market Share in Value by Application in 2025 Figure 47. North America Verapamil Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Verapamil Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Verapamil Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Verapamil Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Verapamil Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Verapamil Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Verapamil Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Verapamil Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Verapamil Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Verapamil Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Verapamil Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Verapamil Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Verapamil Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Verapamil Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Verapamil Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Verapamil Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Verapamil Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Verapamil Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Verapamil Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Verapamil Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Verapamil Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Verapamil Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Capsules
  • Tablets
  • Injection
  • Others
Applications
  • Hospital Pharmacy
  • Online Sales
  • Retail Pharmacy
  • Others
Companies covered
  • REPLEK FARM
  • YUNGSHIN PHARM IND. CO. LTD
  • The Central Pharmaceutical CO.,Ltd.Tianjin
  • Mylan
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Verapamil Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Verapamil Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Verapamil Market by Type
  6. 1.3.1 Capsules
  7. 1.3.2 Tablets
  8. 1.3.3 Injection
  9. 1.3.4 Others
  10. 1.4 Global Verapamil Market Size by Type
  11. 1.4.1 Global Verapamil Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Verapamil Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Verapamil Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Verapamil Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Verapamil Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Verapamil Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Verapamil Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Verapamil Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Verapamil Industry Trends
  2. 2.2 Verapamil Industry Drivers
  3. 2.3 Verapamil Industry Opportunities and Challenges
  4. 2.4 Verapamil Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Verapamil Revenue (2021-2026)
  2. 3.2 Global Top Players by Verapamil Sales (2021-2026)
  3. 3.3 Global Top Players by Verapamil Price (2021-2026)
  4. 3.4 Global Verapamil Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Verapamil Major Company Production Sites & Headquarters
  6. 3.6 Global Verapamil Company, Product Type & Application
  7. 3.7 Global Verapamil Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Verapamil Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Verapamil Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Verapamil Tier 1, Tier 2, and Tier 3
4 Verapamil Regional Status and Outlook
  1. 4.1 Global Verapamil Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Verapamil Historic Market Size by Region
  3. 4.2.1 Global Verapamil Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Verapamil Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Verapamil Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Verapamil Forecasted Market Size by Region
  7. 4.3.1 Global Verapamil Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Verapamil Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Verapamil Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Verapamil by Application
  1. 5.1 Verapamil Market by Application
  2. 5.1.1 Hospital Pharmacy
  3. 5.1.2 Online Sales
  4. 5.1.3 Retail Pharmacy
  5. 5.1.4 Others
  6. 5.2 Global Verapamil Market Size by Application
  7. 5.2.1 Global Verapamil Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Verapamil Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Verapamil Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Verapamil Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Verapamil Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Verapamil Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Verapamil Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Verapamil Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 REPLEK FARM
  2. 6.1.1 REPLEK FARM Company Information
  3. 6.1.2 REPLEK FARM Business Overview
  4. 6.1.3 REPLEK FARM Verapamil Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 REPLEK FARM Verapamil Product Portfolio
  6. 6.1.5 REPLEK FARM Recent Developments
  7. 6.2 YUNGSHIN PHARM IND. CO. LTD
  8. 6.2.1 YUNGSHIN PHARM IND. CO. LTD Company Information
  9. 6.2.2 YUNGSHIN PHARM IND. CO. LTD Business Overview
  10. 6.2.3 YUNGSHIN PHARM IND. CO. LTD Verapamil Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 YUNGSHIN PHARM IND. CO. LTD Verapamil Product Portfolio
  12. 6.2.5 YUNGSHIN PHARM IND. CO. LTD Recent Developments
  13. 6.3 The Central Pharmaceutical CO.,Ltd.Tianjin
  14. 6.3.1 The Central Pharmaceutical CO.,Ltd.Tianjin Company Information
  15. 6.3.2 The Central Pharmaceutical CO.,Ltd.Tianjin Business Overview
  16. 6.3.3 The Central Pharmaceutical CO.,Ltd.Tianjin Verapamil Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 The Central Pharmaceutical CO.,Ltd.Tianjin Verapamil Product Portfolio
  18. 6.3.5 The Central Pharmaceutical CO.,Ltd.Tianjin Recent Developments
  19. 6.4 Mylan
  20. 6.4.1 Mylan Company Information
  21. 6.4.2 Mylan Business Overview
  22. 6.4.3 Mylan Verapamil Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Mylan Verapamil Product Portfolio
  24. 6.4.5 Mylan Recent Developments
  25. 6.5 Abbott Laboratories
  26. 6.5.1 Abbott Laboratories Company Information
  27. 6.5.2 Abbott Laboratories Business Overview
  28. 6.5.3 Abbott Laboratories Verapamil Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Abbott Laboratories Verapamil Product Portfolio
  30. 6.5.5 Abbott Laboratories Recent Developments
7 North America by Country
  1. 7.1 North America Verapamil Sales by Country
  2. 7.1.1 North America Verapamil Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Verapamil Sales by Country (2021-2026)
  4. 7.1.3 North America Verapamil Sales Forecast by Country (2027-2032)
  5. 7.2 North America Verapamil Market Size by Country
  6. 7.2.1 North America Verapamil Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Verapamil Market Size by Country (2021-2026)
  8. 7.2.3 North America Verapamil Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Verapamil Sales by Country
  2. 8.1.1 Europe Verapamil Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Verapamil Sales by Country (2021-2026)
  4. 8.1.3 Europe Verapamil Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Verapamil Market Size by Country
  6. 8.2.1 Europe Verapamil Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Verapamil Market Size by Country (2021-2026)
  8. 8.2.3 Europe Verapamil Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Verapamil Sales by Country
  2. 9.1.1 Asia-Pacific Verapamil Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Verapamil Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Verapamil Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Verapamil Market Size by Country
  6. 9.2.1 Asia-Pacific Verapamil Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Verapamil Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Verapamil Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Verapamil Sales by Country
  2. 10.1.1 South America Verapamil Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Verapamil Sales by Country (2021-2026)
  4. 10.1.3 South America Verapamil Sales Forecast by Country (2027-2032)
  5. 10.2 South America Verapamil Market Size by Country
  6. 10.2.1 South America Verapamil Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Verapamil Market Size by Country (2021-2026)
  8. 10.2.3 South America Verapamil Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Verapamil Sales by Country
  2. 11.1.1 Middle East and Africa Verapamil Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Verapamil Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Verapamil Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Verapamil Market Size by Country
  6. 11.2.1 Middle East and Africa Verapamil Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Verapamil Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Verapamil Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Verapamil Value Chain Analysis
  2. 12.1.1 Verapamil Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Verapamil Production Mode & Process
  7. 12.2 Verapamil Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Verapamil Distributors
  10. 12.2.3 Verapamil Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst